These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10075592

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy.
    Kaufman DB, Leventhal JR, Stuart J, Parker M, Abecassis M, Fryer JP, Stuart FP.
    Transplant Proc; 1999; 31(1-2):615-6. PubMed ID: 10083261
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG, Winoto J, Chhabra D, Parker MA, Leventhal JR, Kaufman DB.
    Transplantation; 2007 May 27; 83(10):1324-9. PubMed ID: 17519781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
    Reddy KS, Stratta RJ, Shokouh-Amiri H, Alloway R, Somerville T, Egidi MF, Gaber LW, Gaber AO.
    Transplantation; 2000 Jan 15; 69(1):49-54. PubMed ID: 10653379
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
    Fabrega AJ, Corwin CL, Hunsicker L.
    Transplant Proc; 1998 Jun 15; 30(4):1562-3. PubMed ID: 9636634
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients.
    el-Ghoroury M, Hariharan S, Peddi VR, Munda R, Schroeder TJ, Demmy AM, Alexander JW, First MR.
    Transplant Proc; 1997 Jun 15; 29(1-2):649-51. PubMed ID: 9123461
    [No Abstract] [Full Text] [Related]

  • 11. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC, Loss GE, Grewal HP, Siegel CT, Pellar S, Josephson MA, Thistlethwaite JR.
    Transplant Proc; 1998 Jun 27; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin.
    Schulz T, Martin D, Heimes M, Klempnauer J, Buesing M.
    Transplant Proc; 1998 Jun 27; 30(4):1533-5. PubMed ID: 9636623
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.